Palivizumab
Palivizumab
Immunglobulin G1 (human-mouse monoclonal MEDI-493γ1-chain antirespiratory syncytial virus protein F), disulfide with human-mouse monoclonal MEDI-493κ-chain, dimer
Stoffgruppe
Spezifisches Immunglobulin
Halbwertszeit
20 Tage